Total Payments
$2,545
2024 Payments
$959.07
Companies
33
Transactions
140
Medicare Patients
578
Medicare Billing
$54,935
Payment Breakdown by Category
Food & Beverage$2,545 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,545 | 140 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $413.69 | 37 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $280.10 | 11 | $0 (2023) |
| ABBVIE INC. | $232.19 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $186.16 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $177.20 | 10 | $0 (2024) |
| Genentech USA, Inc. | $148.85 | 6 | $0 (2024) |
| GENZYME CORPORATION | $110.83 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $88.95 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $73.89 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $71.35 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $959.07 | 54 | Celgene Corporation ($216.23) |
| 2023 | $652.81 | 39 | Celgene Corporation ($142.22) |
| 2022 | $837.57 | 45 | Pharmacyclics LLC, an AbbVie Company ($133.68) |
| 2021 | $95.64 | 2 | Pharmacyclics LLC, An AbbVie Company ($79.31) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $10.41 | General |
| Category: Hematology | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: Hematology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: BioOncology | ||||||
| 11/20/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: CELLT | ||||||
| 11/05/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $24.89 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.21 | General |
| 10/23/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Oncology | ||||||
| 10/17/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/10/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Oncology | ||||||
| 10/08/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Oncology | ||||||
| 10/03/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $18.19 | General |
| 09/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Hematology | ||||||
| 09/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $1.52 | General |
| Category: Hematology | ||||||
| 09/11/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Hematology | ||||||
| 08/29/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Oncology | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $11.21 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 99 | 134 | $25,293 | $9,752 |
| 2022 | 2 | 115 | 159 | $28,947 | $11,284 |
| 2021 | 3 | 212 | 269 | $54,067 | $22,506 |
| 2020 | 3 | 152 | 173 | $31,794 | $11,393 |
Total Patients
578
Total Services
735
Medicare Billing
$54,935
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 134 | $25,293 | $9,752 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 140 | $26,425 | $10,390 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 19 | $2,522 | $893.28 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 187 | $35,225 | $14,218 | 40.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 61 | $16,085 | $7,115 | 44.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 21 | $2,757 | $1,172 | 42.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 131 | $24,104 | $8,636 | 35.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 20 | $4,940 | $1,809 | 36.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 22 | $2,750 | $947.98 | 34.5% |
About Julie Maring, P.A
Julie Maring, P.A is a Medical healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104845510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Maring, P.A has received a total of $2,545 in payments from pharmaceutical and medical device companies, with $959.07 received in 2024. These payments were reported across 140 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,545).
As a Medicare-enrolled provider, Maring has provided services to 578 Medicare beneficiaries, totaling 735 services with total Medicare billing of $54,935. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Grand Rapids, MI
- Active Since 07/18/2006
- Last Updated 03/17/2020
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1104845510
Products in Payments
- IMBRUVICA (Drug) $335.56
- REBLOZYL (Biological) $260.16
- VENCLEXTA (Drug) $116.87
- OJJAARA (Drug) $113.22
- Pomalyst (Drug) $102.93
- SARCLISA (Biological) $93.55
- Lenvima (Drug) $68.04
- EPKINLY (Drug) $59.86
- Venclexta (Biological) $55.37
- BLENREP (Biological) $51.17
- ALUNBRIG (Drug) $49.86
- LUTATHERA (Drug) $49.68
- AVASTIN (Drug) $48.02
- SOMATULINE DEPOT (Drug) $47.72
- PROMACTA (Drug) $41.48
- DARZALEX (Biological) $39.73
- NINLARO (Drug) $39.09
- ZEPZELCA (Drug) $38.50
- CALQUENCE (Drug) $38.32
- JAKAFI (Drug) $38.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Grand Rapids
Meredith Kent, Pa, PA
Medical — Payments: $185,546
Medical $185,546
Mrs. Nisha Mckenzie, Pa-C, PA-C
Medical — Payments: $17,063
Medical $17,063
David Barney, Pac, PAC
Medical — Payments: $16,069
Medical $16,069
Mrs. Brenda Wharton, Pa-C, PA-C
Medical — Payments: $7,993
Medical $7,993
Andra Talaska, Pa-C, PA-C
Medical — Payments: $7,985
Medical $7,985
Jennifer Dykhouse, Pa, PA
Medical — Payments: $5,879
Medical $5,879